Prospective and comparative study of paroxysmal nocturnal hemoglobinuria patients treated or not by eculizumab: Focus on platelet extracellular vesicles

ABSTRACT: Thrombosis are severe complications of paroxysmal nocturnal hemoglobinuria (PNH), effectively reduced by eculizumab. Extracellular vesicles (EVs) may play a central role. The objective of this study was to assess the procoagulant activity of plasma isolated from PNH patients (treated or no...

Descripción completa

Detalles Bibliográficos
Autores principales: Devalet, Bérangère, Wannez, Adeline, Bailly, Nicolas, Alpan, Lutfiye, Gheldof, Damien, Douxfils, Jonathan, Bihin, Benoît, Chatelain, Bernard, Dogné, Jean-Michel, Chatelain, Christian, Mullier, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635286/
https://www.ncbi.nlm.nih.gov/pubmed/31277120
http://dx.doi.org/10.1097/MD.0000000000016164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635286/
https://www.ncbi.nlm.nih.gov/pubmed/31277120
http://dx.doi.org/10.1097/MD.0000000000016164

Ejemplares similares